{"id":36961,"date":"2018-02-21T09:00:00","date_gmt":"2018-02-21T07:00:00","guid":{"rendered":"https:\/\/www.ipsen.com\/?post_type=press_release&p=36961"},"modified":"2023-09-06T18:32:07","modified_gmt":"2023-09-06T16:32:07","slug":"arix-bioscience-et-ipsen-concluent-un-accord-strategique-pour-developper-et-commercialiser-des-therapies-innovantes","status":"publish","type":"press_release","link":"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/arix-bioscience-et-ipsen-concluent-un-accord-strategique-pour-developper-et-commercialiser-des-therapies-innovantes\/","title":{"rendered":"Arix Bioscience et Ipsen concluent un accord strat\u00e9gique pour d\u00e9velopper et commercialiser des th\u00e9rapies innovantes"},"content":{"rendered":"

Paris (France) & Londres (Royaume-Uni), le 21 F\u00e9vrier 2018 : <\/b>Arix Bioscience plc (LSE:ARIX) (\u201cArix\u201d), une entreprise internationale de sant\u00e9 et des sciences de la vie soutenant l\u2019innovation m\u00e9dicale, et Ipsen (Euronext: IPN; ADR:IPSEY), groupe biopharmaceutique mondial de sp\u00e9cialit\u00e9 focalis\u00e9 sur l\u2019innovation et la m\u00e9decine de sp\u00e9cialit\u00e9, ont annonc\u00e9 aujourd\u2019hui un accord strat\u00e9gique pour d\u00e9velopper et commercialiser des th\u00e9rapies innovantes.
\nArix va fournir \u00e0 Ipsen l\u2019acc\u00e8s \u00e0 son r\u00e9seau unique d\u2019experts professionnels et scientifiques et va lui permettre d\u2019investir dans des projets existants ou de nouvelles opportunit\u00e9s issus d\u2019Arix. En retour, Ipsen soutiendra Arix par son expertise dans la recherche, le d\u00e9veloppement et l\u2019excellence commerciale. La collaboration entre Arix et Ipsen vise \u00e0 identifier des opportunit\u00e9s et \u00e0 cr\u00e9er conjointement de nouvelles entreprises ciblant principalement le d\u00e9veloppement et la commercialisation de th\u00e9rapeutiques innovantes pour les patients .
\nJoe Anderson, Directeur G\u00e9n\u00e9ral d\u2019Arix Bioscience plc<\/b>, a d\u00e9clar\u00e9 : \u00ab Cet accord va permettre d\u2019associer l\u2019expertise approfondie d\u2019Ipsen dans le d\u00e9veloppement et la commercialisation des m\u00e9dicaments \u00e0 la capacit\u00e9 av\u00e9r\u00e9e d\u2019Arix dans l\u2019identification de nouvelles opportunit\u00e9s et la cr\u00e9ation d\u2019entreprises, pour d\u00e9velopper de nouvelles th\u00e9rapies innovantes, o\u00f9 il existe de forts besoins non satisfaits. Arix s\u2019engage \u00e0 acqu\u00e9rir des int\u00e9r\u00eats dans des innovations m\u00e9dicales et \u00e0 soutenir leur d\u00e9veloppement, et \u00e0 promouvoir des domaines importants o\u00f9 les options th\u00e9rapeutiques sont limit\u00e9es. Nous sommes impatients de travailler avec Ipsen \u00e0 l\u2019identification de nouvelles opportunit\u00e9s pour stimuler l\u2019innovation, am\u00e9liorer les r\u00e9sultats obtenus par les patients et enfin, apporter de la valeur future pour nos actionnaires. \u00bb
\nDavid Meek, Directeur G\u00e9n\u00e9ral d\u2019Ipsen<\/b>, a ajout\u00e9 : \u00ab Nous sommes r\u00e9solus \u00e0 d\u00e9couvrir et d\u00e9velopper des solutions th\u00e9rapeutiques innovantes pour cibler les maladies invalidantes et am\u00e9liorer la qualit\u00e9 de vie des patients. En construisant cette collaboration avec Arix, nous pouvons b\u00e9n\u00e9ficier de leurs r\u00e9seaux et de leurs experts de premier plan, et nous pouvons, en retour, les soutenir gr\u00e2ce \u00e0 nos capacit\u00e9s et \u00e0 nos expertises en R&D et excellence commerciale. Nous sommes impatients de travailler ensemble et de soutenir la prochaine g\u00e9n\u00e9ration d\u2019entreprises d\u00e9veloppant des m\u00e9dicaments qui transformeront la vie des patients. \u00bb
\nArix a investi dans 13 entreprises innovantes dans les sciences de la vie en 2016 et 2017, et de nombreux r\u00e9sultats \u00e0 forte valeur sont attendus au cours des 18 prochains mois. Arix va continuer de construire son pipeline d\u00e9j\u00e0 riche, pour fournir des financements et une expertise \u00e0 de nouvelles entreprises en 2018.<\/p>\n

Pour plus d\u2019informations sur Arix :<\/u><\/b>
\nConsilium Communication Strat\u00e9gique<\/b>
\nMary-Jane Elliott, Jessica Hodgson, Ivar Milligan<\/b>
\n+44 (0)20 3709 5700
\narix@consilium-comms.com<\/b><\/a><\/p>\n

Relations Investisseurs<\/b>
\nCharlotte Parry<\/b>
\nInvestor Relations Manager
\n+44 (0)20 7290 1072
\ncharlotte@arixbioscience.com<\/b><\/a><\/p>\n

Pour plus d\u2019informations sur Ipsen :<\/u><\/b>
\nM\u00e9dias<\/b>
\nIan Weatherhead<\/b>
\nVice-Pr\u00e9sident, Communication Externe Groupe
\n+44 (0) 7584230549
\nian.weatherhead@ipsen.com<\/b><\/a><\/p>\n

Brigitte Le Guennec<\/b>
\nResponsable Senior, Communication Externe Monde
\n+33 (0)1 58 33 51 17
\nbrigitte.le.guennec@ipsen.com<\/p>\n

Communaut\u00e9 financi\u00e8re<\/b>
\nEugenia Litz<\/b>
\nVice-Pr\u00e9sidente Relations Investisseurs
\n+44 (0) 1753 627721
\neugenia.litz@ipsen.com<\/b><\/a><\/p>\n

<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"template":"","categories":[1233,3556],"tags":[],"class_list":["post-36961","press_release","type-press_release","status-publish","hentry","category-pressrelease-fr","category-corporate-pressrelease-fr","entry"],"acf":[],"yoast_head":"\nArix Bioscience et Ipsen concluent un accord strat\u00e9gique pour d\u00e9velopper et commercialiser des th\u00e9rapies innovantes<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/arix-bioscience-et-ipsen-concluent-un-accord-strategique-pour-developper-et-commercialiser-des-therapies-innovantes\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Arix Bioscience et Ipsen concluent un accord strat\u00e9gique pour d\u00e9velopper et commercialiser des th\u00e9rapies innovantes\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/arix-bioscience-et-ipsen-concluent-un-accord-strategique-pour-developper-et-commercialiser-des-therapies-innovantes\/\" \/>\n<meta property=\"og:site_name\" content=\"Global\" \/>\n<meta property=\"article:modified_time\" content=\"2023-09-06T16:32:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ml-eu.globenewswire.com\/media\/MDNiMjE0ZTgtY2YxMS00Y2VmLWEyOTUtY2Q3NWYzYjM5MWMxLTEwMTA5NDM=\/tiny\/Ipsen-SA.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@ipsengroup\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/arix-bioscience-et-ipsen-concluent-un-accord-strategique-pour-developper-et-commercialiser-des-therapies-innovantes\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/arix-bioscience-et-ipsen-concluent-un-accord-strategique-pour-developper-et-commercialiser-des-therapies-innovantes\/\"},\"author\":{\"name\":\"IPSEN\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/05e5e9dcc9e44c61de10732d1d0a1352\"},\"headline\":\"Arix Bioscience et Ipsen concluent un accord strat\u00e9gique pour d\u00e9velopper et commercialiser des th\u00e9rapies innovantes\",\"datePublished\":\"2018-02-21T07:00:00+00:00\",\"dateModified\":\"2023-09-06T16:32:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/arix-bioscience-et-ipsen-concluent-un-accord-strategique-pour-developper-et-commercialiser-des-therapies-innovantes\/\"},\"wordCount\":543,\"publisher\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/arix-bioscience-et-ipsen-concluent-un-accord-strategique-pour-developper-et-commercialiser-des-therapies-innovantes\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ml-eu.globenewswire.com\/media\/MDNiMjE0ZTgtY2YxMS00Y2VmLWEyOTUtY2Q3NWYzYjM5MWMxLTEwMTA5NDM=\/tiny\/Ipsen-SA.png\",\"articleSection\":[\"Communiqu\u00e9 de presse\",\"Corporate\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/arix-bioscience-et-ipsen-concluent-un-accord-strategique-pour-developper-et-commercialiser-des-therapies-innovantes\/\",\"url\":\"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/arix-bioscience-et-ipsen-concluent-un-accord-strategique-pour-developper-et-commercialiser-des-therapies-innovantes\/\",\"name\":\"Arix Bioscience et Ipsen concluent un accord strat\u00e9gique pour d\u00e9velopper et commercialiser des th\u00e9rapies innovantes\",\"isPartOf\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/arix-bioscience-et-ipsen-concluent-un-accord-strategique-pour-developper-et-commercialiser-des-therapies-innovantes\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/arix-bioscience-et-ipsen-concluent-un-accord-strategique-pour-developper-et-commercialiser-des-therapies-innovantes\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ml-eu.globenewswire.com\/media\/MDNiMjE0ZTgtY2YxMS00Y2VmLWEyOTUtY2Q3NWYzYjM5MWMxLTEwMTA5NDM=\/tiny\/Ipsen-SA.png\",\"datePublished\":\"2018-02-21T07:00:00+00:00\",\"dateModified\":\"2023-09-06T16:32:07+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/arix-bioscience-et-ipsen-concluent-un-accord-strategique-pour-developper-et-commercialiser-des-therapies-innovantes\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/arix-bioscience-et-ipsen-concluent-un-accord-strategique-pour-developper-et-commercialiser-des-therapies-innovantes\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/arix-bioscience-et-ipsen-concluent-un-accord-strategique-pour-developper-et-commercialiser-des-therapies-innovantes\/#primaryimage\",\"url\":\"https:\/\/ml-eu.globenewswire.com\/media\/MDNiMjE0ZTgtY2YxMS00Y2VmLWEyOTUtY2Q3NWYzYjM5MWMxLTEwMTA5NDM=\/tiny\/Ipsen-SA.png\",\"contentUrl\":\"https:\/\/ml-eu.globenewswire.com\/media\/MDNiMjE0ZTgtY2YxMS00Y2VmLWEyOTUtY2Q3NWYzYjM5MWMxLTEwMTA5NDM=\/tiny\/Ipsen-SA.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/arix-bioscience-et-ipsen-concluent-un-accord-strategique-pour-developper-et-commercialiser-des-therapies-innovantes\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ipsen.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Arix Bioscience et Ipsen concluent un accord strat\u00e9gique pour d\u00e9velopper et commercialiser des th\u00e9rapies innovantes\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#website\",\"url\":\"https:\/\/www.ipsen.com\/fr\/\",\"name\":\"Global\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ipsen.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#organization\",\"name\":\"IPSEN\",\"url\":\"https:\/\/www.ipsen.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ipsen.com\/wp-content\/uploads\/2023\/12\/Latest_Ipsen-logo_168x48.svg\",\"contentUrl\":\"https:\/\/www.ipsen.com\/wp-content\/uploads\/2023\/12\/Latest_Ipsen-logo_168x48.svg\",\"caption\":\"IPSEN\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Ipsengroup\",\"https:\/\/x.com\/ipsengroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/05e5e9dcc9e44c61de10732d1d0a1352\",\"name\":\"IPSEN\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/b569564123e1c5c4bb45b008fc273d5bfdd6464d8a8497307ebbe91af50ed000?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/b569564123e1c5c4bb45b008fc273d5bfdd6464d8a8497307ebbe91af50ed000?s=96&d=mm&r=g\",\"caption\":\"IPSEN\"},\"sameAs\":[\"https:\/\/www.ipsen.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Arix Bioscience et Ipsen concluent un accord strat\u00e9gique pour d\u00e9velopper et commercialiser des th\u00e9rapies innovantes","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/arix-bioscience-et-ipsen-concluent-un-accord-strategique-pour-developper-et-commercialiser-des-therapies-innovantes\/","og_locale":"fr_FR","og_type":"article","og_title":"Arix Bioscience et Ipsen concluent un accord strat\u00e9gique pour d\u00e9velopper et commercialiser des th\u00e9rapies innovantes","og_url":"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/arix-bioscience-et-ipsen-concluent-un-accord-strategique-pour-developper-et-commercialiser-des-therapies-innovantes\/","og_site_name":"Global","article_modified_time":"2023-09-06T16:32:07+00:00","og_image":[{"url":"https:\/\/ml-eu.globenewswire.com\/media\/MDNiMjE0ZTgtY2YxMS00Y2VmLWEyOTUtY2Q3NWYzYjM5MWMxLTEwMTA5NDM=\/tiny\/Ipsen-SA.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_site":"@ipsengroup","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/arix-bioscience-et-ipsen-concluent-un-accord-strategique-pour-developper-et-commercialiser-des-therapies-innovantes\/#article","isPartOf":{"@id":"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/arix-bioscience-et-ipsen-concluent-un-accord-strategique-pour-developper-et-commercialiser-des-therapies-innovantes\/"},"author":{"name":"IPSEN","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/05e5e9dcc9e44c61de10732d1d0a1352"},"headline":"Arix Bioscience et Ipsen concluent un accord strat\u00e9gique pour d\u00e9velopper et commercialiser des th\u00e9rapies innovantes","datePublished":"2018-02-21T07:00:00+00:00","dateModified":"2023-09-06T16:32:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/arix-bioscience-et-ipsen-concluent-un-accord-strategique-pour-developper-et-commercialiser-des-therapies-innovantes\/"},"wordCount":543,"publisher":{"@id":"https:\/\/www.ipsen.com\/fr\/#organization"},"image":{"@id":"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/arix-bioscience-et-ipsen-concluent-un-accord-strategique-pour-developper-et-commercialiser-des-therapies-innovantes\/#primaryimage"},"thumbnailUrl":"https:\/\/ml-eu.globenewswire.com\/media\/MDNiMjE0ZTgtY2YxMS00Y2VmLWEyOTUtY2Q3NWYzYjM5MWMxLTEwMTA5NDM=\/tiny\/Ipsen-SA.png","articleSection":["Communiqu\u00e9 de presse","Corporate"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/arix-bioscience-et-ipsen-concluent-un-accord-strategique-pour-developper-et-commercialiser-des-therapies-innovantes\/","url":"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/arix-bioscience-et-ipsen-concluent-un-accord-strategique-pour-developper-et-commercialiser-des-therapies-innovantes\/","name":"Arix Bioscience et Ipsen concluent un accord strat\u00e9gique pour d\u00e9velopper et commercialiser des th\u00e9rapies innovantes","isPartOf":{"@id":"https:\/\/www.ipsen.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/arix-bioscience-et-ipsen-concluent-un-accord-strategique-pour-developper-et-commercialiser-des-therapies-innovantes\/#primaryimage"},"image":{"@id":"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/arix-bioscience-et-ipsen-concluent-un-accord-strategique-pour-developper-et-commercialiser-des-therapies-innovantes\/#primaryimage"},"thumbnailUrl":"https:\/\/ml-eu.globenewswire.com\/media\/MDNiMjE0ZTgtY2YxMS00Y2VmLWEyOTUtY2Q3NWYzYjM5MWMxLTEwMTA5NDM=\/tiny\/Ipsen-SA.png","datePublished":"2018-02-21T07:00:00+00:00","dateModified":"2023-09-06T16:32:07+00:00","breadcrumb":{"@id":"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/arix-bioscience-et-ipsen-concluent-un-accord-strategique-pour-developper-et-commercialiser-des-therapies-innovantes\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ipsen.com\/fr\/communique-de-presse\/arix-bioscience-et-ipsen-concluent-un-accord-strategique-pour-developper-et-commercialiser-des-therapies-innovantes\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/arix-bioscience-et-ipsen-concluent-un-accord-strategique-pour-developper-et-commercialiser-des-therapies-innovantes\/#primaryimage","url":"https:\/\/ml-eu.globenewswire.com\/media\/MDNiMjE0ZTgtY2YxMS00Y2VmLWEyOTUtY2Q3NWYzYjM5MWMxLTEwMTA5NDM=\/tiny\/Ipsen-SA.png","contentUrl":"https:\/\/ml-eu.globenewswire.com\/media\/MDNiMjE0ZTgtY2YxMS00Y2VmLWEyOTUtY2Q3NWYzYjM5MWMxLTEwMTA5NDM=\/tiny\/Ipsen-SA.png"},{"@type":"BreadcrumbList","@id":"https:\/\/www.ipsen.com\/fr\/communique-de-presse\/arix-bioscience-et-ipsen-concluent-un-accord-strategique-pour-developper-et-commercialiser-des-therapies-innovantes\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ipsen.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Arix Bioscience et Ipsen concluent un accord strat\u00e9gique pour d\u00e9velopper et commercialiser des th\u00e9rapies innovantes"}]},{"@type":"WebSite","@id":"https:\/\/www.ipsen.com\/fr\/#website","url":"https:\/\/www.ipsen.com\/fr\/","name":"Global","description":"","publisher":{"@id":"https:\/\/www.ipsen.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ipsen.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.ipsen.com\/fr\/#organization","name":"IPSEN","url":"https:\/\/www.ipsen.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2023\/12\/Latest_Ipsen-logo_168x48.svg","contentUrl":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2023\/12\/Latest_Ipsen-logo_168x48.svg","caption":"IPSEN"},"image":{"@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Ipsengroup","https:\/\/x.com\/ipsengroup"]},{"@type":"Person","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/05e5e9dcc9e44c61de10732d1d0a1352","name":"IPSEN","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/b569564123e1c5c4bb45b008fc273d5bfdd6464d8a8497307ebbe91af50ed000?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b569564123e1c5c4bb45b008fc273d5bfdd6464d8a8497307ebbe91af50ed000?s=96&d=mm&r=g","caption":"IPSEN"},"sameAs":["https:\/\/www.ipsen.com"]}]}},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/press_release\/36961","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/press_release"}],"about":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/types\/press_release"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"version-history":[{"count":2,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/press_release\/36961\/revisions"}],"predecessor-version":[{"id":36966,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/press_release\/36961\/revisions\/36966"}],"wp:attachment":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/media?parent=36961"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/categories?post=36961"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/tags?post=36961"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}